Finally,
combination therapy with luteolin and paclitaxel significantly reduced tumor size and tumor weight in
an orthotopic tumor model of MDA-MB-231 cells in nude mice. These results suggest that the luteolin–paclitaxel
combination could be a novel strategy for the treatment of breast cancer